Recuperación de los valores de proteínas y anticuerpos específicos en donantes especiales tratados con Trofín

Castellanos Martínez, Rosa; Ochoa Zaldivar, Manuel; Aznar García, Elisa; González Hernández, Raúl.
Medisan ; 10(1)ene.-mar. 2006. tab, graf
Artículo en Español | LILACS | ID: lil-463360

Documentos relacionados

  1. Timing of hypotensive adverse events in U.S. source plasma donors: Exploratory analysis from the IMPACT trial.
  2. Limited evidence, lasting decisions: How voluntary non-remunerated plasma donations can avoid the commercial one-way street.
  3. The availability of plasma donors and plasma: A sociologist's perspective.
  4. Amber coloured plasma-Case for illustration.
  5. MEDICAL AND ECONOMIC ANALYSIS OF THE CHOICE OF THERAPEUTIC PLASMAPHERESIS METHOD TO OPTIMIZE THE TRANSFUSION CARE QUALITY.
  6. Evaluation of a routine hematology analyzer for quality control of leukoreduced plasma.
  7. Detection of Nonenveloped Hepatitis E Virus in Plasma of Infected Blood Donors.
  8. UK donor plasma could have an immediate beneficial effect on the availability of plasma-derived medicinal products in Europe.
  9. Europe needs 2 million extra donors of blood and plasma: How to find them?
  10. A donor safety evidence literature review of the short- and long-term effects of plasmapheresis.